Published :
Tables : 190
Figures : 30
Category : Healthcare
No. of Pages : 180
Report Code : HC-1187
Apoptosis Assays Market Introduction: Apoptosis assays market is anticipated to value around USD 7.5 billion by 2027 end and register a CAGR of over 9.7% from the forecast period 2020-2027. The mounting funds assigned for cancer research coupled with innovations on apoptosis assays drugs are the driving factors expanding the market. Additionally, increased cell-based research along with rising cases of infectious diseases is positively influencing the market. The market is bifurcated into by product, by detection technology, by application, by end-user and region. In terms of product, assay kits are expected to dominate the growth of the market. The ability of assay kits to detect nuclear changes coupled with the adoption of assay kits in multiple procedures like environmental monitoring, life science research is stimulating the market. It is also used in the screening of drug candidates, evaluating biopharmaceutical production processes and studying diseases. Owing to these features, assay kits are expected to hold a majority share of the market. In terms of detection technology, cell imaging and microscopy are forecasted to witness notable growth owing to the increasing preference towards cell imaging and microscopy in drug discovery applications, basic research, and diagnostic laboratories. Based on application, drug discovery and development holds a vast share of the market. The increasing prevalence and incidence of infectious and chronic diseases are driving the demand for drug discovery and development. The increasing research and development activities coupled with mounting government efforts taken to develop new treatments for multiple diseases is expanding the apoptosis synthesis market size. North America is the global leader of the market. Increasing incidences of chronic diseases and soaring investments for cancer research is fueling the market growth in the region. Furthermore, soaring research and development activities alongside favourable government policies in the region are boosting the market presence in the region. Asia-Pacific region is expected to be a lucrative region owing to increased spending on the healthcare sector and the presence of a larger patient population. Moreover, the presence of a large number of local players coupled with increasing cases of infectious diseases is positively influencing the market in the region. Prominent players of the market are: Danaher Corporation, BioTek Instruments, Promega Corporation, PerkinElmer, Abcam plc, Abnova, Creative Bioarray, Thermo Fisher Scientific, Merck KgaA, Becton, GE Healthcare, Dickinson and Company, Geno Technology GeneCopoeia, Inc and Sartorius. Competitive Landscape: Merck acquired Sigma Aldrich Corporation. The move helped Merck to strengthen its life science segment Thermo Fisher Scientific in 2018, launched Multiskan Sky Microplate Spectrophotometer Dickinson and Company and Becton in 2017 acquired C.R Bard GE Healthcare Life Sciences opened its new manufacturing site in Austria in 2018. The move will help the company strengthen its product supply all over Europe Apoptosis Assays Market Segmentation: By Product Assay Kits Caspase Assays Annexin V and Cell Permeability Assays DNA Fragmentation Assay Mitochondrial Assays Microplates Instruments Reagents By Detection Technology ● Flow Cytometry ● Cell Imaging & Analysis Systems ● Spectrophotometry ● Other Detection Technologies By Application ● Basic Research ● Clinical & Diagnostic Applications ● Drug Discovery & Development ● Stem Cell Research By End User ● Hospital and Diagnostic Laboratories ● Pharmaceutical and Biotechnology Companies ● Academic and Research Institutes By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Rest of the World FutureWise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the apoptosis market by product, by detection technology, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • Evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Apoptosis assays market is anticipated to value around USD 7.5 billion by 2027 end and register a CAGR of over 9.7% from the forecast period 2020-2027.
The mounting funds assigned for cancer research coupled with innovations on apoptosis assays drugs are the driving factors expanding the market. Additionally, increased cell-based research along with rising cases of infectious diseases is positively influencing the market. The market is bifurcated into by product, by detection technology, by application, by end-user and region. In terms of product, assay kits are expected to dominate the growth of the market. The ability of assay kits to detect nuclear changes coupled with the adoption of assay kits in multiple procedures like environmental monitoring, life science research is stimulating the market. It is also used in the screening of drug candidates, evaluating biopharmaceutical production processes and studying diseases. Owing to these features, assay kits are expected to hold a majority share of the market. In terms of detection technology, cell imaging and microscopy are forecasted to witness notable growth owing to the increasing preference towards cell imaging and microscopy in drug discovery applications, basic research, and diagnostic laboratories. Based on application, drug discovery and development holds a vast share of the market. The increasing prevalence and incidence of infectious and chronic diseases are driving the demand for drug discovery and development. The increasing research and development activities coupled with mounting government efforts taken to develop new treatments for multiple diseases is expanding the apoptosis synthesis market size.
North America is the global leader of the market. Increasing incidences of chronic diseases and soaring investments for cancer research is fueling the market growth in the region. Furthermore, soaring research and development activities alongside favourable government policies in the region are boosting the market presence in the region.
Asia-Pacific region is expected to be a lucrative region owing to increased spending on the healthcare sector and the presence of a larger patient population. Moreover, the presence of a large number of local players coupled with increasing cases of infectious diseases is positively influencing the market in the region.
Prominent players of the market are: Danaher Corporation, BioTek Instruments, Promega Corporation, PerkinElmer, Abcam plc, Abnova, Creative Bioarray, Thermo Fisher Scientific, Merck KgaA, Becton, GE Healthcare, Dickinson and Company, Geno Technology GeneCopoeia, Inc and Sartorius.
Competitive Landscape:
Apoptosis Assays Market Segmentation:
By Product
By Detection Technology ● Flow Cytometry ● Cell Imaging & Analysis Systems ● Spectrophotometry ● Other Detection Technologies
By Application ● Basic Research ● Clinical & Diagnostic Applications ● Drug Discovery & Development ● Stem Cell Research
By End User ● Hospital and Diagnostic Laboratories ● Pharmaceutical and Biotechnology Companies ● Academic and Research Institutes
By Region ● North America ● Europe ● Asia Pacific ● Latin America ● Rest of the World
FutureWise Key Takeaways ● Growth Prospects ● SWOT Analysis ● Key Trends ● Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the apoptosis market by product, by detection technology, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • Evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Apoptosis Assays Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Apoptosis Assays Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Apoptosis Assays Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Apoptosis Assays Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Apoptosis Assays Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1 Assay Kits 7.1.1. Caspase Assays 7.1.2. Annexin V and Cell Permeability Assays 7.1.3. DNA Fragmentation Assay 7.1.4. Mitochondrial Assays 7.2. Microplates 7.3. Instruments 7.4. Reagents 8. Global Apoptosis Assays Market, By Detection Technology Historical Analysis and Forecast 2020-2027 (USD Million) 8.1 Flow Cytometry 8.2 Cell Imaging & Analysis Systems 8.3 Spectrophotometry 8.4 Other Detection Technologies 9. Global Apoptosis Assays Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1 Basic Research 9.2 Clinical & Diagnostic Applications 9.3 Drug Discovery & Development 9.4 Stem Cell Research 10. Global Apoptosis Assays Market, By End-User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Hospital and Diagnostic Laboratories 10.2. Pharmaceutical and Biotechnology Companies 10.3. Academic and Research Institutes 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1 Danaher Corporation 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 BioTek Instruments 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Promega Corporation 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 PerkinElmer 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Abcam plc 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Abnova 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 Creative Bioarray 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Thermo Fisher Scientific 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 Merck KgaA 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 Becton 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11 GE Healthcare 16.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12 Dickinson and Company 16.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13 Geno Technology 16.13.1. Company Overview (HQ, Business Segments, Employee Strength) 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14 GeneCopoeia, Inc 16.14.1. Company Overview (HQ, Business Segments, Employee Strength) 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15 Sartorius 16.15.1. Company Overview (HQ, Business Segments, Employee Strength) 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics